Progenity's Series B Round

Progenity raised a round of funding on November 07, 2017. Investors include Athyrium Capital Management.

Progenity, formerly Ascendant MDX, is a biotechnology company with a presence in Women's Health molecular testing and a pipeline of proprietary tests and therapeutic applications under development. Pr…

Articles about Progenity's Series B Round: